Section: Endocrine Sub-section: Parathyroid

Overview

  • Very rare
  • Can present with extreme hypercalcaemia, severe bone disease, or renal stones.
  • Other symptoms include weakness, extreme tiredness, confusion, nausea and vomiting, weight loss, polyuria
  • 50% of patients will present with a palpable neck mass (which never occurs with an adenoma).

Causes

  • Association Hyperparathyroidism-Jaw Tumour syndrome
    • Germline CDC73 mutations
      • Encode a protein parafibromin which is a tumour suppressor gene - many sporadic cancers also exhibit mutations in this gene.
    • Parafibromin is stained for on histology - as malignant tumours generally have loss of parafibromin.

Pathology

  • Appear as greyish-white, and adherent to adjacent structures, like the thyroid, trachea, and neck muscles.
  • Histology
    • Bizarre nuclear atypia
    • Mitotic figures
    • Capsular invasion
  • Only definitive criteria for malignancy
    • Local invasion
    • Metastatic disease
      • Lung, liver, LNs

Treatment 

  • Must be prepared to do oncologic resection if required on exploration
    • Classically find adherence to surrounding structures or invasion intra-operatively, with dense scarring
  • If suspected pre-op
    • “At risk group”
    • Severe hypercalcaemia, very high PTH, and palpable tumour
  • Perform En-bloc resection of parathyroid tumour, ipsilateral thyroid lobe, ipsilateral parathyroid, and adjacent nodes
    • May have to sacrifice RLN if invaded
  • Routinely explore contralateral parathyroids
  • If diagnosis made post-op after parathyroidectomy
    • Re-operate and remove ipsilateral thyroid and parathyroid, and LNs